Literature DB >> 15485752

Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlled.

Peter Bramlage1, David Pittrow, Hans-Ulrich Wittchen, Wilhelm Kirch, Steffen Boehler, Hendrik Lehnert, Michael Hoefler, Thomas Unger, Arya M Sharma.   

Abstract

BACKGROUND: Although the relationship between body weight and blood pressure (BP) is well established, there is a lack of data regarding the impact of obesity on the prevalence of hypertension in primary care practice. The objective of this study was to assess the prevalence of hypertension and the diagnosis, treatment status, and control rates of hypertension in obese patients as compared to patients with normal weight.
METHODS: A cross-sectional point prevalence study of 45,125 unselected consecutive primary care attendees was conducted in a representative nationwide sample of 1912 primary care physicians in Germany (HYDRA).
RESULTS: Blood pressure levels were consistently higher in obese patients. Overall prevalence of hypertension (blood pressure >/=140/90 mm Hg or on antihypertensive medication) in normal weight patients was 34.3%, in overweight participants 60.6%, in grade 1 obesity 72.9%, in grade 2 obesity 77.1%, and in grade 3 obesity 74.1%. The odds ratio (OR) for good BP control (<140/90 mm Hg) in diagnosed and treated patients was 0.8 (95% confidence interval [CI] 0.7-0.9) in overweight patients, 0.6 (95% CI 0.6-0.7) in grade 1, 0.5 (95% CI 0.4-0.6) in grade 2, and 0.7 (95% CI 0.5-0.9) in grade 3 obese patients.
CONCLUSIONS: The increasing prevalence of hypertension in obese patients and the low control rates in overweight and obese patients document the challenge that hypertension control in obese patients imposes on the primary care physician. These results highlight the need for specific evidence-based guidelines for the pharmacologic management of obesity-related hypertension in primary practice.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15485752     DOI: 10.1016/j.amjhyper.2004.05.017

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  90 in total

1.  Na+-sensitive elevation in blood pressure is ENaC independent in diet-induced obesity and insulin resistance.

Authors:  Jonathan M Nizar; Wuxing Dong; Robert B McClellan; Mariana Labarca; Yuehan Zhou; Jared Wong; Donald G Goens; Mingming Zhao; Nona Velarde; Daniel Bernstein; Michael Pellizzon; Lisa M Satlin; Vivek Bhalla
Journal:  Am J Physiol Renal Physiol       Date:  2016-02-03

2.  Metaboreflex activation delays heart rate recovery after aerobic exercise in never-treated hypertensive men.

Authors:  Tiago Peçanha; Leandro Campos de Brito; Rafael Yokoyama Fecchio; Patricia Nascimento de Sousa; Natan Daniel da Silva Junior; Andrea Pio de Abreu; Giovanio Vieira da Silva; Décio Mion-Junior; Cláudia Lúcia de Moraes Forjaz
Journal:  J Physiol       Date:  2016-09-21       Impact factor: 5.182

Review 3.  Management of hypertension in overweight and obese patients: a practical guide for clinicians.

Authors:  Francesco Dentali; Arya M Sharma; James D Douketis
Journal:  Curr Hypertens Rep       Date:  2005-10       Impact factor: 5.369

Review 4.  Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors.

Authors:  M R Meyer; D J Clegg; E R Prossnitz; M Barton
Journal:  Acta Physiol (Oxf)       Date:  2011-02-01       Impact factor: 6.311

5.  Achieving Weight Loss and Hypertension Control Among Obese Adults: A US Multidisciplinary Group Practice Observational Study.

Authors:  Aaron K Ho; Christie M Bartels; Carolyn T Thorpe; Nancy Pandhi; Maureen A Smith; Heather M Johnson
Journal:  Am J Hypertens       Date:  2016-02-24       Impact factor: 2.689

6.  Effectiveness of A Four-Week Diet Regimen, Exercise and Psychological Intervention for Weight Loss.

Authors:  Tobias Weinreich; Hans-Peter Filz; Ursula Gresser; Barbara M Richartz
Journal:  J Clin Diagn Res       Date:  2017-03-01

7.  Leptin Induces Hypertension Acting on Transient Receptor Potential Melastatin 7 Channel in the Carotid Body.

Authors:  Mi-Kyung Shin; Candela Caballero Eraso; Yun-Ping Mu; Chenjuan Gu; Bonnie H Y Yeung; Lenise J Kim; Xiao-Ru Liu; Zhi-Juan Wu; Omkar Paudel; Luis E Pichard; Machiko Shirahata; Wan-Yee Tang; James S K Sham; Vsevolod Y Polotsky
Journal:  Circ Res       Date:  2019-09-23       Impact factor: 17.367

Review 8.  Drug mechanisms to help in managing resistant hypertension in obesity.

Authors:  Pieter M Jansen; Jan A H Danser; Wilko Spiering; Anton H van den Meiracker
Journal:  Curr Hypertens Rep       Date:  2010-08       Impact factor: 5.369

Review 9.  Management of hypertension in the elderly patient.

Authors:  Gordon Stewart Stokes
Journal:  Clin Interv Aging       Date:  2009-10-12       Impact factor: 4.458

Review 10.  Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors.

Authors:  Eduardo Pimenta; Suzanne Oparil
Journal:  Vasc Health Risk Manag       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.